We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Phase I dose escalation of iodine-131-metaiodobenzylguanidine with myeloablative chemotherapy and autologous stem-cell transplantation in refractory neuroblastoma: a new approaches to Neuroblastoma Therapy Consortium Study.
- Authors
Matthay, Katherine K; Tan, Jessica C; Villablanca, Judith G; Yanik, Gregory A; Veatch, Janet; Franc, Benjamin; Twomey, Eilish; Horn, Biljana; Reynolds, C Patrick; Groshen, Susan; Seeger, Robert C; Maris, John M
- Abstract
To determine the maximum-tolerated dose (MTD) and toxicity of iodine-131-metaiodobenzylguanidine ((131)I-MIBG) with carboplatin, etoposide, melphalan (CEM) and autologous stem-cell transplantation (ASCT) in refractory neuroblastoma.
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2006, Vol 24, Issue 3, p500
- ISSN
1527-7755
- Publication type
Journal Article
- DOI
10.1200/JCO.2005.03.6400